4
Changes in Ownership
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001992260-25-000008
EVP, Head of R&D sold 196,538 shares at an average $37.55 ($7,379,887)
- EVP, Head of R&D acquired 196,538 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Option exercise 10b5-1 | +83,978 | $8.44 | $708,774 | 87,978 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Option exercise 10b5-1 | +3,529 | $17.88 | $63,099 | 91,507 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Sale 10b5-1 | −26,166 | $35.80 | $936,743 | 65,341 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Sale 10b5-1 | −42,765 | $37.04 | $1,584,016 | 22,576 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Sale 10b5-1 | −18,576 | $37.72 | $700,687 | 4,000 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise 10b5-1 | +40,287 | $17.88 | $720,332 | 44,287 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise 10b5-1 | +37,494 | $21.77 | $816,244 | 81,781 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise 10b5-1 | +31,250 | $22.07 | $689,688 | 113,031 | D |
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Sale 10b5-1 | −109,031 | $38.14 | $4,158,442 | 4,000 | D |
| Derivatives | |||||||
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −83,978 | 11,996 | D | ||
| Randhawa Simrat EVP, Head of R&D | 2025-11-13 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,529 | 116,471 | D | ||
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −40,287 | 76,184 | D | ||
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −37,494 | 62,506 | D | ||
| Randhawa Simrat EVP, Head of R&D | 2025-11-14 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −31,250 | 118,750 | D | ||
| Open-market sales · 196,538 sh · avg $37.55 · $7,379,887 | |||||||
Loading xslF345X05/ownership.xml…